HomeESLAW • NASDAQ
add
Estrella Immunopharma
Previous close
$0.036
Year range
$0.027 - $0.19
Market cap
41.85M USD
Avg Volume
934.00
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 469.53K | -82.87% |
Net income | -469.53K | 82.87% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.73M | 77.79% |
Total assets | 8.63M | 178.39% |
Total liabilities | 138.49K | -98.08% |
Total equity | 8.49M | — |
Shares outstanding | 36.38M | — |
Price to book | 0.16 | — |
Return on assets | -12.98% | — |
Return on capital | -13.37% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -469.53K | 82.87% |
Cash from operations | -4.23M | -4,914.13% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -84.09K | — |
Net change in cash | -4.32M | -1,854.29% |
Free cash flow | -4.06M | -554.15% |
About
Headquarters
Website